Oncology Industry Blog

I published a new business article in Nature Biopharma Dealmakers together with Christiaan de Bloeme and my colleagues at Aglaia. The...

On August 2021, I lead the development of an business article on exiting oncology ventures in Nature Biotechnology when I worked as a...

Platform technologies, product engines that can generate novel drug candidates or identify new drug targets, are popular these days in...

ESMO Targeted Anticancer Therapies Congress 2022 For many tumor types whole arsenals of therapies are now available, most strikingly for...